SEC Form 4 · accession 0001382963-15-000097
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Smith
Director
Period of report
Jul 17, 2015
Accepted (ET)
Jul 21, 2015 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 17, 2015 | M | 1,375 | — | A | 1,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jul 17, 2015 | M | 1,375 | D | — | — | Common Stock | 1,375 | 4,125 | D |
| Stock Option (right to buy)F3 | $5.60 | holding | — | — | — | — | Jul 17, 2024 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive the economic equivalent of one share of Issuer's common stock, payable in shares of common stock, cash or some combination of both, as determined by the Issuer.
- F2On July 17, 2014, the reporting person was granted 5,500 restricted stock units. The restricted stock units became payable in four equal annual installments beginning on July 17, 2015.
- F3Stock option vests in four equal annual installments beginning on July 17, 2015.